|
Respiratory Syncytial Virus (RSV) is a respiratory virus that infects the lungs and breathing passages. It is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children under 1 year of age in the United States. In addition, RSV is more often being recognized as an important cause of respiratory illness in older adults.
Otherwise healthy people recover from RSV infection in 1 to 2 weeks. However, infection can be severe in children with cardiopulmonary disease and in those born prematurely. Elderly are also an at-risk population. (www3.niaid.nih.gov). In normal infants and children, the virus is shed for two to three weeks overall or one to two weeks after the children appear in the hospital. Because of its high infectivity and because hospital staff as well as patients are susceptible, RSV has emerged as the most frequent cause of infections on pediatric wards.
As with other respiratory viruses, RSV causes a range of respiratory illnesses, the most common being a cold with profuse rhinorrhea. RSV infections appear in large outbreaks every winter. It is very contagious, and most children have experienced infection by two years of age. (http://www.cdc.gov/RSV)
Meridian Life Science, Inc. (MLS) is introducing a new Monoclonal Antibody to RSV:
Catalog # C66432M
MAb to Respiratory Syncytial Virus (RSV) Nucleoprotein
Clone # 25-2
- Specificity – Recognizes the nucleoprotein of RSV in extract of live virus
(Long Strain – ATCC # VR-26™)
- Host Animal – Mouse
- Source – Ascites
- Format – Liquid, Purified
- Purification - ≥ 90% pure
- Buffer – 10mM Sodium phosphate, 150mM Sodium chloride, pH 7.4
This monoclonal antibody is suitable for use in dot blot and lateral flow applications.
For more information including pricing and availability, please contact us at info1@meridianlifescience.com.
View all of our RSV products here.
Please forward this email to a friend or colleague that may have similar interests or needs.
|